Bill > HB1422

This bill modifies Washington state's drug take-back program by updating several key regulatory provisions. It requires program operators to submit more detailed annual reports to the Department of Health, including expanded information about drug collection amounts, collection sites, public education efforts, recycling of packaging, program goals, and financial expenditures. The bill also strengthens the department's oversight capabilities by allowing it to audit program records, investigate complaints, and require revisions to submitted reports within 30 days. Additionally, the bill adjusts fee structures for program operators, limiting annual fees to 10% of the highest annual expenditures from any single program operator and introducing a one-time $70,000 fee split among approved operators to fund an expedited review by the joint legislative audit and review committee. The legislation mandates that the committee conduct a comprehensive review of the department's fee-setting authority by December 31, 2025, to ensure that administrative costs are appropriately covered and expenditures are transparent. The bill also maintains the existing sunset provision, which repeals the drug take-back program laws effective January 1, 2030, allowing for future legislative reassessment of the program.

Budget and Finance, Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=1422&Year=2025&Initiative=false